Drugs / CD34+ selected bone marrow mononuclear cells
CD34+ selected bone marrow mononuclear cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00383630 | Sep 2007 → Dec 2008 | congestive heart failure | Columbia University | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ selected bone marrow mononuclear cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00383630 ↗ |
| Modality | Cell therapy | “immunoselected CD34+ hematopoietic stem cells” NCT00383630 ↗ |
| Route | Other | “Intramyocardial injection of CD34+ selected bone marrow mononuclear cells” NCT00383630 ↗ |